Literature DB >> 17027514

Transcription factors mediating interleukin-3 survival signals.

Jeffrey Jong-Young Yen1, Hsin-Fang Yang-Yen.   

Abstract

Interleukin-3 (IL-3) is one of the major hematopoietic cytokines that regulate the survival of hematopoietic cells of various lineages. Although the mechanism underlying the survival effect of IL-3 has been investigated intensively for more than a decade, our knowledge of the survival-signaling network remains incomplete. Binding of IL-3 to its cognate receptors initiates rapid tyrosine phosphorylation of Janus kinases (JAKs) and of signal transducer and activator of transcription (STAT) proteins, as well as activation of the phosphatidylinositol-3 kinase (PI-3K)/Akt and Ras/Raf/MAPK kinase (MEK)/mitogen-activated protein kinase (MAPK) pathways. These signals culminate in induction of a constellation of antiapoptotic genes and prevent cell death from occurring. Thus IL-3 signaling has substantial effects on kinase activation and gene transcription. Previous articles have summarized the roles of these kinase pathways in cell proliferation and survival. In this chapter, we will focus on the role of several newly characterized transcriptional factors, which are targets of these initial kinase cascades and bridge the gap between kinases and survival effector genes, in transducing the IL-3 survival signal. The biological significance of the existence of these multiple survival-specific transcription pathways will also be discussed. (c) 2006 Elsevier Inc.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17027514     DOI: 10.1016/S0083-6729(06)74006-7

Source DB:  PubMed          Journal:  Vitam Horm        ISSN: 0083-6729            Impact factor:   3.421


  3 in total

1.  The novel structure make LDM effectively remove CD123+ AML stem cells in combination with interleukin 3.

Authors:  Yanjun Zhang; Rong Liu; Dongmei Fan; Rizan Shi; Ming Yang; Qingfang Miao; Zhao-Qun Deng; Jun Qian; Yongsu Zhen; Dongsheng Xiong; Jianxiang Wang
Journal:  Cancer Biol Ther       Date:  2015-07-17       Impact factor: 4.742

2.  Murine Th9 cells promote the survival of myeloid dendritic cells in cancer immunotherapy.

Authors:  Jungsun Park; Haiyan Li; Mingjun Zhang; Yong Lu; Bangxing Hong; Yuhuan Zheng; Jin He; Jing Yang; Jianfei Qian; Qing Yi
Journal:  Cancer Immunol Immunother       Date:  2014-05-20       Impact factor: 6.968

3.  IL-3 and oncogenic Abl regulate the myeloblast transcriptome by altering mRNA stability.

Authors:  Jason Ernst; Louis Ghanem; Ziv Bar-Joseph; Michael McNamara; Jason Brown; Richard A Steinman
Journal:  PLoS One       Date:  2009-10-15       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.